Prognostic and predictive value of blood eosinophil count, fractional exhaled nitric oxide and their combination in severe asthma: a post-hoc analysis
Үндсэн зохиолчид: | Shrimanker, R, Keene, O, Hynes, G, Wenzel, S, Yancey, S, Pavord, I |
---|---|
Формат: | Journal article |
Хэл сонгох: | English |
Хэвлэсэн: |
American Thoracic Society
2019
|
Ижил төстэй зүйлс
Ижил төстэй зүйлс
-
Fractional exhaled nitric oxide and the peripheral blood eosinophil count as biomarkers of the response to mepolizumab in patients with severe eosinophilic asthma
-н: Shrimanker, R, зэрэг
Хэвлэсэн: (2018) -
Association of elevated fractional exhaled nitric oxide concentration and blood eosinophil count with severe asthma exacerbations
-н: Price, D, зэрэг
Хэвлэсэн: (2019) -
Association of elevated fractional exhaled nitric oxide concentration and blood eosinophil count with severe asthma exacerbations
-н: David B. Price, зэрэг
Хэвлэсэн: (2019-08-01) -
Diagnostic possibility of the combination of exhaled nitric oxide and blood eosinophil count for eosinophilic asthma
-н: Jiang-Hua Li, зэрэг
Хэвлэсэн: (2021-08-01) -
Clinical characterisation of exacerbations of severe eosinophilic asthma occurring on mepolizumab and placebo
-н: Howell, I, зэрэг
Хэвлэсэн: (2024)